Peptides for sleep and deep rest
Good sleep isn't one thing — it's a cycle your brain conducts in stages, and delta-wave (deep) sleep does much of the physical restoration. This topic collects articles on how sleep works and on peptides for sleep, like DSIP, the delta sleep-inducing peptide.
You'll find mechanisms, honest evidence reviews, and practical sleep science rather than promises. Anything prescribed comes only after a licensed provider reviews your request. None of this replaces the basics — the articles are clear about where sleep hygiene ends and pharmacology begins.
6 articles on this topic
-

DSIP Benefits: What the Human Evidence Shows
DSIP has been studied most directly for sleep, but the human findings are small, old and mixed. Signals involving ACTH, chronic pain and withdrawal are preliminary rather than established benefits.
-

DSIP Side Effects: What Human Studies Found
Reported DSIP side effects include sleep pressure, headache, nausea, vertigo, sweating and occasional blood-pressure changes, but small, short studies leave long-term risk largely unknown.
-

Tirzepatide for Sleep Apnea: What Was Approved
In December 2024 Zepbound became the first medicine approved in the United States for moderate-to-severe obstructive sleep apnea in adults with obesity. The trials behind it are specific, and so is what that approval does and does not cover.
-

DSIP Dosage: What the Human Studies Used
There is no standard clinical dose for delta sleep-inducing peptide. The small human studies used intravenous infusions under observation, not a validated at-home schedule.
-

Epitalon Benefits, Sorted by Evidence Tier
The most-cited animal experiment gave 54 mice per group monthly doses for life and found mean lifespan unchanged, maximum lifespan up 12.3%, and leukemia down six-fold.
-

The DSIP Peptide: A 1970s Sleep Mystery
The DSIP peptide was isolated from the blood of sleeping rabbits in 1970s Switzerland, yet no one has ever found its receptor — or the gene that would prove mammals make it.